% Encoding: UTF-8

@Article{Zabor2022,
  author  = {Zabor, Emily C and Kaizer, Alexander M and Garrett-Mayer, Elizabeth and Hobbs, Brian P},
  journal = {JCO Precision Oncology},
  title   = {Optimal sequential predictive probability designs for early-phase oncology expansion cohorts},
  year    = {2022},
  month   = mar,
  number  = {6},
  pages   = {e2100390},
  volume  = {6},
  doi     = {10.1200/PO.21.00390},
}

@Article{Petrylak2018,
  author  = {Petrylak, D. P. and Powles, T. and Bellmunt, J. and Braiteh, F. and Loriot, Y. and Morales-Barrera, R. and Burris, H. A. and Kim, J. W. and Ding, B. and Kaiser, C. and Fassò, M. and O'Hear, C. and Vogelzang, N. J.},
  journal = {JAMA Oncol},
  title   = {Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study},
  year    = {2018},
  issn    = {2374-2437 (Print)
2374-2437},
  number  = {4},
  pages   = {537-544},
  volume  = {4},
  doi     = {10.1001/jamaoncol.2017.5440},
  type    = {Journal Article},
}

@Article{Rosenberg2016,
  author  = {Rosenberg, J. E. and Hoffman-Censits, J. and Powles, T. and van der Heijden, M. S. and Balar, A. V. and Necchi, A. and Dawson, N. and O'Donnell, P. H. and Balmanoukian, A. and Loriot, Y. and Srinivas, S. and Retz, M. M. and Grivas, P. and Joseph, R. W. and Galsky, M. D. and Fleming, M. T. and Petrylak, D. P. and Perez-Gracia, J. L. and Burris, H. A. and Castellano, D. and Canil, C. and Bellmunt, J. and Bajorin, D. and Nickles, D. and Bourgon, R. and Frampton, G. M. and Cui, N. and Mariathasan, S. and Abidoye, O. and Fine, G. D. and Dreicer, R.},
  journal = {Lancet},
  title   = {Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial},
  year    = {2016},
  issn    = {0140-6736 (Print)
0140-6736},
  number  = {10031},
  pages   = {1909-20},
  volume  = {387},
  doi     = {10.1016/s0140-6736(16)00561-4},
  type    = {Journal Article},
}

@Article{Powles2018,
  author  = {Powles, T. and Durán, I. and van der Heijden, M. S. and Loriot, Y. and Vogelzang, N. J. and De Giorgi, U. and Oudard, S. and Retz, M. M. and Castellano, D. and Bamias, A. and Fléchon, A. and Gravis, G. and Hussain, S. and Takano, T. and Leng, N. and Kadel, E. E., 3rd and Banchereau, R. and Hegde, P. S. and Mariathasan, S. and Cui, N. and Shen, X. and Derleth, C. L. and Green, M. C. and Ravaud, A.},
  journal = {Lancet},
  title   = {Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial},
  year    = {2018},
  issn    = {0140-6736},
  number  = {10122},
  pages   = {748-757},
  volume  = {391},
  doi     = {10.1016/s0140-6736(17)33297-x},
  type    = {Journal Article},
}

@Comment{jabref-meta: databaseType:bibtex;}
